Cellectis S.A annual r&d spending
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Cellectis S.A R&D Spending Growth & History (CLLS)
Cellectis S.A's r&d spending was $93.5M for fiscal 2025.
View full Cellectis S.A company overviewCellectis S.A annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $93.5M | $3.0M | +3.29% |
| 2024 | 2024-12-31 | $90.5M | $2.9M | +3.30% |
| 2023 | 2023-12-31 | $87.6M | −$9.9M | −10.11% |
| 2022 | 2022-12-31 | $97.5M | −$20.3M | −17.26% |
| 2021 | 2021-12-31 | $117.8M | $40.8M | +52.94% |
| 2020 | 2020-12-31 | $77.0M | −$15.0M | −16.29% |
| 2019 | 2019-12-31 | $92.0M | $15.5M | +20.21% |
| 2018 | 2018-12-31 | $76.6M | −$2.7M | −3.36% |
| 2017 | 2017-12-31 | $79.2M | $769,000 | +0.98% |
| 2016 | 2016-12-31 | $78.5M | $20.3M | +34.91% |
| 2015 | 2015-12-31 | $58.2M | — | — |
Cellectis S.A quarterly r&d spending
Q2.19
Q2.20
Q2.21
Q2.22
Q2.23
Q2.24
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $25.0M | $1.9M | +8.21% |
| Q1 2026 | 2026-03-31 | $27.2M | — | — |
| Q4 2025 | 2025-12-31 | $24.4M | — | — |
| Q3 2025 | 2025-09-30 | $24.1M | — | — |
| Q2 2025 | 2025-06-30 | $23.1M | −$438,000 | −1.86% |
| Q2 2024 | 2024-06-30 | $23.5M | $1.3M | +5.94% |
| Q2 2023 | 2023-06-30 | $22.2M | −$3.4M | −13.38% |
| Q2 2022 | 2022-06-30 | $25.6M | −$5.5M | −17.71% |
| Q2 2021 | 2021-06-30 | $31.1M | $8.3M | +36.24% |
| Q2 2020 | 2020-06-30 | $22.9M | −$2.6M | −10.07% |
| Q2 2019 | 2019-06-30 | $25.4M | — | — |
Cellectis S.A r&d spending trends
Over the last five fiscal years, Cellectis S.A's r&d spending increased from $77.0M to $93.5M, a change of $16.5M. The latest reported quarter, Q2 2026, shows $25.0M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cellectis S.A source filings ↗